Karyotypic abnormalities in myelofibrosis following polycythemia vera
- 15 January 2003
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 140 (2) , 118-123
- https://doi.org/10.1016/s0165-4608(02)00678-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasiaBritish Journal of Haematology, 2001
- Myelofibrosis with Myeloid MetaplasiaNew England Journal of Medicine, 2000
- Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 casesLeukemia, 1999
- Translocation (1;20)(q32;q13.3) in myelofibrosis following polycythemia vera.Cancer Genetics and Cytogenetics, 1998
- Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 casesBritish Journal of Haematology, 1997
- Dicentric (1;15) in myeloid disordersCancer Genetics and Cytogenetics, 1996
- Clinical significance of the del(20q) chromosome in hematologic disordersCancer Genetics and Cytogenetics, 1992
- Chromosome Studies in 104 Patients With Polycythemia VeraMayo Clinic Proceedings, 1991
- A chromosomal profile of polycythemia veraCancer Genetics and Cytogenetics, 1987
- The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosisCancer, 1985